HUTCHMED Secures $110 Million Licensing Deal with GSK for Promising Solid Tumour Drug, ETPharma
Shanghai: GSK subsidiary GlaxoSmithKline Intellectual Property (No. 4) Ltd will pay a unit of HUTCHMED (China) $110 million…
GSK Announces £400m Investment in Cambridge Hub
GlaxoSmithKline (GSK) is planning to invest £400m in a major new science hub in Cambridge as it looks…
Nuvalent director’s awards cashed out in GSK deal
SEC Form 4 FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP…
Suddenly investors can’t get enough of GSK shares! What’s going on?
Image source: Getty Images It’s been a long wait, but GSK (LSE: GSK) shares are finally in demand.…